Skip to content
SEC filings edition: Friday, November 13, 2026 · 767 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Monday, November 16, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 13, 2026 1bankruptcies 11delisting notices 12late filings 43leadership changes 6IPO filings 199private raises 90earnings releases
Company page · CIK 1709941 · BIOA

BioAge Labs, Inc.

Filing with the SEC SEC-reporting company Emeryville, CA Nasdaq
An email when it files something new with the SEC. Your account

What this means

  • Net loss in 2025Net loss of $80.6M for the year (2024: −$71.1M).

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Financials from XBRL

Calendar-year frame20252024
Revenue$9M$0
Net income (loss)−$80.6M−$71.1M
Total assets$295M$358M
Total liabilities$22.8M$35.1M
Stockholders’ equity$272M$323M
Cash and equivalents$189M$354M

From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.

Name as filed
BioAge Labs, Inc.
CIK
0001709941
Tickers
BIOA
Kind of filer
SEC-reporting company
Non-accelerated filer; Smaller reporting company; Emerging growth company
Status
Filing with the SEC
State of incorporation
Delaware
Business address
Emeryville, California
Industry (SIC)
2834 · Pharmaceutical preparations
Industry: D · Manufacturing →
Fiscal year ends
December 31
Last annual report
10-K for the period ended Dec 31, 2025
Last quarterly report
10-Q for the quarter ended Sep 30, 2026
Bankruptcy reported
Not in our data
Last edition event
Nov 5, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2026
    Form 10-Q · filed Nov 5, 2026 · filing · edition of Nov 5, 2026
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 5, 2026 · filing · edition of Nov 5, 2026
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 5, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2026
    Form 10-Q · filed Aug 5, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2026
    Form 10-Q · filed May 8, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 8, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed Mar 24, 2026 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2025
    Form 10-K · filed Mar 24, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 6, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2025
    Form 10-Q · filed Nov 6, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 6, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2025
    Form 10-Q · filed Aug 6, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 6, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2025
    Form 10-Q · filed May 6, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Mar 20, 2025 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2024
    Form 10-K · filed Mar 20, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 7, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2024
    Form 10-Q · filed Nov 7, 2024 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SC 13D · filed Oct 4, 2024 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SC 13D · filed Sep 30, 2024 · filing
  • IPO prospectus (424B4): Final prospectus (424B4)
    Form 424B4 · filed Sep 26, 2024 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Sep 3, 2024 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Feb 13, 2024 · filing